Literature DB >> 2476448

Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase.

K Bebenek1, J Abbotts, J D Roberts, S H Wilson, T A Kunkel.   

Abstract

DNA-dependent DNA synthesis in vitro by human immunodeficiency virus-1 reverse transcriptase is relatively error-prone. The enzyme, whether recombinant or from virus particles, produces errors while replicating M13mp2 DNA at a rate that, if operative in vivo, would produce about five mutations per genome per round of replication. Sequence analysis of mutants resulting from in vitro synthesis demonstrates that errors are nonrandomly distributed. Base substitution and one-base frameshift mutational hot spots are observed. The specificity and position of errors suggest that most of the frameshifts and many of the base substitutions are initiated by template-primer slippage. Processivity analysis for the enzyme on the M13mp2 DNA template reveals strong termination at specific sites. Termination sites within homopolymer sequences correlate with frameshift mutational hot spots. The results suggest that the formation and/or utilization of misaligned template-primers is increased during the dissociation-reinitiation phase of the reaction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476448

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  112 in total

1.  Mutation spectra of herpes simplex virus type 1 thymidine kinase mutants.

Authors:  Qiaosheng Lu; Ying T Hwang; Charles B C Hwang
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

2.  Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis.

Authors:  Q X Hu; A P Barry; Z X Wang; S M Connolly; S C Peiper; M L Greenberg
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1.

Authors:  J S Smith; S Y Kim; M J Roth
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Analysis of selection pressure and mutational pattern of HIV type 1 reverse transcriptase region among treated and nontreated patients.

Authors:  Uma Shanmugasundaram; Suniti Solomon; Vidya Madhavan; Murugavel G Kailapuri; Kumarasamy Nagalingeswaran; Sunil Suhas Solomon; Kenneth H Mayer; Balakrishnan Pachamuthu
Journal:  AIDS Res Hum Retroviruses       Date:  2010-09-19       Impact factor: 2.205

5.  Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.

Authors:  Michael E Abram; Andrea L Ferris; Wei Shao; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

Review 6.  Viral mutation rates.

Authors:  Rafael Sanjuán; Miguel R Nebot; Nicola Chirico; Louis M Mansky; Robert Belshaw
Journal:  J Virol       Date:  2010-07-21       Impact factor: 5.103

7.  APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis.

Authors:  Holly A Sadler; Mark D Stenglein; Reuben S Harris; Louis M Mansky
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

8.  Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity.

Authors:  E K Halvas; E S Svarovskaia; V K Pathak
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  A screen in Escherichia coli for nucleoside analogs that target human immunodeficiency virus (HIV) reverse transcriptase: coexpression of HIV reverse transcriptase and herpes simplex virus thymidine kinase.

Authors:  B Kim; L A Loeb
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.